Cathie Wood
CSTL icon

Cathie Wood’s Castle Biosciences CSTL Stock Holding History

Cathie Wood’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,170,111
Closed -$27.2M – 352
2022
Q1 		$52.5M Sell
1,170,111
-43,096
-4% -$1.78M 0.22% 66
2021
Q4 		$52M Sell
1,213,207
-844,660
-41% -$44.1M 0.16% 84
2021
Q3 		$137M Sell
2,057,867
-467,746
-19% -$32.9M 0.33% 57
2021
Q2 		$185M Sell
2,525,613
-71,675
-3% -$4.73M 0.34% 64
2021
Q1 		$178M Buy
2,597,288
+528,696
+26% +$39.7M 0.35% 68
2020
Q4 		$139M Buy
2,068,592
+1,620,867
+362% +$87.9M 0.37% 62
2020
Q3 		$23M Sell
447,725
-26,045
-5% -$1.16M 0.14% 84
2020
Q2 		$17.9M Buy
473,770
+253,318
+115% +$8.66M 0.19% 65
2020
Q1 		$6.57M Buy
220,452
+14,438
+7% +$436K 0.16% 68
2019
Q4 		$7.08M Buy
206,014
+39,927
+24% +$976K 0.18% 66
2019
Q3 		$3M Buy
+166,087
New +$3.68M 0.07% 88

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Cathie Wood's CSTL Position: Q2 2022 in Review

Cathie Wood sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 1,170,111 shares — an estimated $27.2M sold.

Cathie Wood first reported a position in CSTL in Q3 2019 and held it in 11 quarters. The position peaked at $185M in Q2 2021. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Cathie Wood reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Cathie Wood sold 1,170,111 Castle Biosciences shares in Q2 2022, an estimated $27.2M.
  • Cathie Wood first reported a position in Castle Biosciences in Q3 2019 and held it in 11 quarters.
  • Cathie Wood's Castle Biosciences position peaked at $185M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on ARK Investment Management's 13F filing for Q2 2022, filed 11 Jul 2022.